Drug Pipeline

Soquelitinib Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
3
Recruiting
1
Phase 3
2
Top Sponsors
Active Studies by Phase
Phase 3
1
Phase 2
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06561048 Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral… Peripheral T-Cell Lymphoma, Not Otherwise Specified Recruiting
Phase 2
NCT07441395 Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD Atopic Dermatitis Recruiting
NCT06730126 Study of the ITK Inhibitor Soquelitinib to Reduce Lymphoproliferation and Improve… Autoimmune Lymphoproliferative Syndrome Recruiting
Sponsors Running Soquelitinib Trials
Corvus Pharmaceuticals, Inc. (2) National Institute of Allergy and Infectious Diseases (NIAID) (1)
Disease Areas
Atopic Dermatitis (1)
Get alerts when Soquelitinib trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free